(Q35188947)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12891189 AND SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

Role of lipid and lipoprotein profiles in risk assessment and therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12891189 AND SRC:MED&resulttype=core&format=json

6 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12891189 AND SRC:MED&resulttype=core&format=json

6 November 2019

Christie M. Ballantyne

series ordinal

1

object named as

Christie M Ballantyne

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12891189 AND SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 August 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12891189 AND SRC:MED&resulttype=core&format=json

6 November 2019

published in

American Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12891189 AND SRC:MED&resulttype=core&format=json

6 November 2019

volume

146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12891189 AND SRC:MED&resulttype=core&format=json

6 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12891189 AND SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

227-233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12891189 AND SRC:MED&resulttype=core&format=json

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Pro and con: high-density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Laboratory surrogates for anti-atherosclerotic drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Fasting Insulin and Apolipoprotein B Levels and Low-Density Lipoprotein Particle Size as Risk Factors for Ischemic Heart Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Hypertriglyceridemia, Atherogenic Dyslipidemia, and the Metabolic Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Dense low density lipoproteins and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Münster Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Summary estimates of cholesterol used to predict coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Plasma lipids and cardiovascular risk: a POSCH report. Program on the Surgical Control of the Hyperlipidemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Efficacy of lipid profiles in prediction of coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Cholesterol and coronary heart disease: predicting risks by levels and ratios

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

Lipids and risk of coronary heart disease. The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0002-8703(02)94701-0

10.1016/S0002-8703(02)94701-0

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12891189 AND SRC:MED&resulttype=core&format=json

6 November 2019

1 reference